Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy

Dr Nicholas McGranahan - Crick Institute, London, UK
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy ( Dr Nicholas McGranahan - Crick Institute, London, UK )
26 Apr 2016

Risk of breast cancer after chest radiotherapy may be affected by genetics

Dr Lindsay Morton - National Cancer Institute, Bethesda, USA
Risk of breast cancer after chest radiotherapy may be affected by genetics ( Dr Lindsay Morton - National Cancer Institute, Bethesda, USA )
26 Apr 2016

Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy

Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA
Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy ( Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA )
26 Apr 2016

NY-ESO-1 immunotherapy for ovarian cancer

Dr Kunle Odunsi - Roswell Park Cancer Institute, Buffalo, USA
NY-ESO-1 immunotherapy for ovarian cancer ( Dr Kunle Odunsi - Roswell Park Cancer Institute, Buffalo, USA )
26 Apr 2016

Imaging tumour habitats - life at the edge

Robert Gillies - Moffitt Cancer Center, Tampa, USA
Imaging tumour habitats - life at the edge ( Robert Gillies - Moffitt Cancer Center, Tampa, USA )
26 Apr 2016

Normal and neoplastic stem cells

Prof Irving L Weissman - Stanford University School of Medicine, Stanford, USA
Normal and neoplastic stem cells ( Prof Irving L Weissman - Stanford University School of Medicine, Stanford, USA )
26 Apr 2016

WIN 2016: Preview of themes

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
WIN 2016: Preview of themes ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
22 Apr 2016

WIN 2016: Preview of Speakers

Dr John Mendelsohn - Chairman of the WIN Consortium
WIN 2016: Preview of Speakers ( Dr John Mendelsohn - Chairman of the WIN Consortium )
22 Apr 2016

Management of CLL patients in the front-line setting: live broadcast

Dr Catherine Hood, Dr Robin Foà, Dr Patrick Thornton, and Prof Stephan Stilgenbauer
Management of CLL patients in the front-line setting: live broadcast ( Dr Catherine Hood, Dr Robin Foà, Dr Patrick Thornton, and Prof Stephan Stilgenbauer )
19 Apr 2016

Update on new agents in multiple myeloma – focus on monoclonal antibodies: an expert roundtable discussion

Michel Delforge, Hermann Einsele, Philippe Moreau and Niels van de Donk
Update on new agents in multiple myeloma – focus on monoclonal antibodies: an expert roundtable discussion ( Michel Delforge, Hermann Einsele, Philippe Moreau and Niels van de Donk )
19 Apr 2016

Novel agents before and after stem cell transplantation for myeloma

Dr Enrique Ocio - Universidad de Salamanca, Salamanca, Spain
Novel agents before and after stem cell transplantation for myeloma ( Dr Enrique Ocio - Universidad de Salamanca, Salamanca, Spain )
12 Apr 2016

Immunology highlights from the ITOC-3 conference

Prof Heinz Zwierzina - Innsbruck University, Innsbruck, Austria
Immunology highlights from the ITOC-3 conference ( Prof Heinz Zwierzina - Innsbruck University, Innsbruck, Austria )
12 Apr 2016